Tevogen Bio Inc.
TVGN | NASDAQ
$5.66
-$0.39 (-6.45%)
At close: Oct 30, 2026, 3:59 PM ET
$5.90
+$0.24 (+4.24%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Company Profile
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.
Key Executives
| Name | Position |
|---|---|
| Olivia Dunlea | Chief of Staff to Chief Executive Officer |
| Ryan H. Saadi | Co-Founder, Chief Executive Officer & Chairperson |
| Kirti Desai | Chief Financial Officer |
| Mittul Mehta | Chief Information Officer & Head of Tevogen.ai |
| David E. Banko | Global Head of Government Affairs & Patient Access |
| Neal Flomenberg | Chief Scientific Officer and Global R&D Lead |
| Sadiq Khan | Chief Commercial Officer & Interim Head of Tevogen Generics |
| Stephen Chen | Chief Technical Officer |
| Tapan V. Shah | Head of Investor Relations & Corporate Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 30, 2026 | 8-K | Current Report |
| Sep 16, 2026 | SC 13D/A | [Amend] Filing |
| Sep 16, 2026 | SC 13D/A | [Amend] Filing |
| Sep 16, 2026 | 4 | Filing |
| Sep 16, 2026 | 4 | Filing |
| Sep 16, 2026 | 8-K | Current Report |
| Sep 15, 2026 | 4 | Filing |
| Sep 15, 2026 | 4 | Filing |
| Sep 15, 2026 | 4 | Filing |
| Sep 15, 2026 | 4 | Filing |
Tevogen Bio Inc.
| Country | United States |
| IPO Date | Jan 5, 2022 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 18 |
| CEO | Ryan H. Saadi |
Contact Details
15 Independence Blvd Warren,
New Jersey 07059 United States
Stock Details
| Ticker Symbol | TVGN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001860871 |
| CUSIP Number | 88165K200 |
| ISIN Number | US88165K2006 |
| SIC Code | 2836 |
Add to Watchlist
Select watchlists to add or remove TVGN